[1]
Çokgezer, S. et al. 2026. Real-World Survival Outcomes of Adjuvant Chemotherapy Versus Endocrine Therapy Alone in Hormone Receptor- Positive, Human Epidermal Growth Factor Receptor 2-Negative Invasive Lobular Carcinoma. Cerrahpaşa Medical Journal. 50, (Jun. 2026), 1–11. DOI:https://doi.org/10.5152/cjm.2026.26038.